CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target.

Feng, Xiaojie; Bai, Xupeng; Ni, Jie; Wasinger, Valerie C; Beretov, Julia; Zhu, Ying; Graham, Peter; Li, Yong

Feng, Xiaojie; Bai, Xupeng; Ni, Jie; Wasinger, Valerie C; Beretov, Julia; Zhu, Ying; Graham, Peter; Li, Yong.

Afiliação

Feng X; Department of Gynaecological Oncology, Henan Cancer Hospital, Zhengzhou, China.
Bai X; Cancer Care Centre, St. George Hospital, Kogarah, NSW, Australia.
Ni J; St. George and Sutherland Clinical School, University of New South Wales Sydney, Sydney, NSW, Australia.
Wasinger VC; Cancer Care Centre, St. George Hospital, Kogarah, NSW, Australia.
Beretov J; St. George and Sutherland Clinical School, University of New South Wales Sydney, Sydney, NSW, Australia.
Zhu Y; Cancer Care Centre, St. George Hospital, Kogarah, NSW, Australia.
Graham P; St. George and Sutherland Clinical School, University of New South Wales Sydney, Sydney, NSW, Australia.
Li Y; Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, University of New South Wales Sydney, Sydney, NSW, Australia.

Front Oncol ; 9: 557, 2019.

Article em En | MEDLINE | ID: mdl-31380263

Palavras-chave

CHTOP; apoptosis; chemoresistance; metastasis; ovarian cancer; stemness

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google